DIAGNOSED WITH HOFH

Clinical trials for DIAGNOSED WITH HOFH explained in plain language.

Never miss a new study

Get alerted when new DIAGNOSED WITH HOFH trials appear

Sign up with your email to follow new studies for DIAGNOSED WITH HOFH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New shot takes aim at stubborn genetic cholesterol

Disease control Not yet recruiting

This study tests an experimental injection called SYH2070 in 18 adults with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The main goal is to see how much the drug lowers LDL (bad) cholesterol. Participants must alre…

Matched conditions: DIAGNOSED WITH HOFH

Phase: PHASE2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 11:09 UTC

DIAGNOSED WITH HOFH

Get alerted when new DIAGNOSED WITH HOFH trials appear

New shot takes aim at stubborn genetic cholesterol